• Klara Mosterd, Aimee H M M Arits, Monique R T Thissen, and Nicole W J Kelleners-Smeets.
• Department of Dermatology, University Hospital Maastricht, Maastricht, The Netherlands. k.mosterd@mumc.nl
• Acta Derm. Venereol. 2009 Jan 1; 89 (5): 454-8.

AbstractBasal cell carcinoma is the most common type of skin cancer and its incidence is still rising. In recent years, new treatment modalities have been developed and existing modalities refined. The aim of this article is to give a histology-based overview of the available evidence-based research. The literature was searched for randomized controlled trials from which the efficacy of investigated treatments was obtained. Where possible, treatment modalities were evaluated specifically. Selection criteria were histological subtype, primary or recurrent basal cell carcinoma and tumour localization. Although surgery remains the preferred treatment for most basal cell carcinomas, patient and tumour characteristics should be taken into account when choosing the most suitable treatment.

24 keywords...

hide…